AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇳🇬
Everolimus in Nigeria
3 products registered with NAFDAC — 2 active, 1 expired
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| Certican 0.25 mg Tablet** Tablet | A4-4292 | Novartis Nigeria Limited | active | 30 Oct 2029 |
| Certican 1 mg Tablet** Tablet | A4-4290 | Novartis Nigeria Limited | active | 1 Dec 2026 |
| CERTICAN 0.5MG TABLET 6 X 10 | A4-4291 B4-6905 | NORVATIS NIG. LTD. MANSARD PLACE | expired | 30 Mar 2022 |
Everolimus — NAFDAC Registration Details
NAFDAC (Nigeria) has 3 registered products containing Everolimus, of which 2 are currently active. Data is sourced directly from the official NAFDAC drug register and refreshed daily.
Track Everolimus registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.